
Molecule: PALIFERMIN
ChEMBL ID: CHEMBL1201821
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005

Molecule: REGORAFENIB
ChEMBL ID: CHEMBL1946170
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2012

Molecule: RG-1530
ChEMBL ID: CHEMBL1980391
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LUCITANIB
ChEMBL ID: CHEMBL2220486
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TG100-801
ChEMBL ID: CHEMBL403989
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TRAFERMIN
ChEMBL ID: CHEMBL2108081
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: PEMIGATINIB
ChEMBL ID: CHEMBL4297522
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: APRUTUMAB IXADOTIN
ChEMBL ID: CHEMBL4650293
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody drug conjugate

Molecule: E-7090
ChEMBL ID: CHEMBL3686884
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FGFR INHIBITOR DEBIO 1347
ChEMBL ID: CHEMBL3907479
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: HMPL-453
ChEMBL ID: CHEMBL4650297
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: BEMARITUZUMAB
ChEMBL ID: CHEMBL4802165
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: BEMARITUZUMAB
ChEMBL ID: CHEMBL4802165
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: NINTEDANIB ESYLATE
ChEMBL ID: CHEMBL3039504
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: ENMD-981693
ChEMBL ID: CHEMBL52885
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DERAZANTINIB
ChEMBL ID: CHEMBL4297187
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ROGARATINIB
ChEMBL ID: CHEMBL3963485
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CP-459632
ChEMBL ID: CHEMBL3545300
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LY-2874455
ChEMBL ID: CHEMBL3545264
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: AZD-4547
ChEMBL ID: CHEMBL3184679
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: XL-999
ChEMBL ID: CHEMBL5314391
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: INFIGRATINIB
ChEMBL ID: CHEMBL1852688
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: BRIVANIB
ChEMBL ID: CHEMBL377300
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: BRIVANIB ALANINATE
ChEMBL ID: CHEMBL270995
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ORANTINIB
ChEMBL ID: CHEMBL274654
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ERDAFITINIB
ChEMBL ID: CHEMBL3545376
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: FUTIBATINIB
ChEMBL ID: CHEMBL3701238
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2022

Molecule: INFIGRATINIB PHOSPHATE
ChEMBL ID: CHEMBL1834657
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021
